David Malcom Rodman
Chief Medical Officer · 19 filings · Latest: Aug 10, 2026
Mineralys Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLYS | David Malcom Rodman | Chief Medical Officer | Mar 13, 2026 | Option Exercise | $12.39 | 7,709 | $95.5K | 90,198 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Mar 12, 2026 | Sale | $27.37 | 6,348 | $173.7K | 82,489 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Mar 12, 2026 | Option Exercise | $1.08 | 6,348 | $6.9K | 88,837 | |
MLYS | Rodman David Malcom | — | Mar 13, 2026 | Proposed Sale | $26.26 | 14,058 | $369.2K | — | |
MLYS | Rodman David Malcom | — | Mar 12, 2026 | Proposed Sale | $27.37 | 6,348 | $173.7K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Mar 9, 2026 | Sale | $26.84 | 2,171 | $58.3K | 82,489 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Mar 9, 2026 | Option Exercise | $16.00 | 2,171 | $34.7K | 84,660 | |
MLYS | Rodman David Malcom | — | Mar 9, 2026 | Proposed Sale | $26.84 | 2,171 | $58.3K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 17, 2026 | Sale | $27.59 | 417 | $11.5K | 44,089 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 17, 2026 | Option Exercise | $15.44 | 417 | $6.4K | 44,506 | |
MLYS | Rodman David Malcom | — | Feb 17, 2026 | Proposed Sale | $27.59 | 417 | $11.5K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 13, 2026 | Sale | $27.44 | 14,055 | $385.7K | 44,089 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 13, 2026 | Option Exercise | $12.39 | 7,707 | $95.5K | 54,603 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 12, 2026 | Sale | $28.99 | 6,349 | $184.1K | 50,437 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 12, 2026 | Option Exercise | $1.08 | 6,349 | $6.9K | 56,786 | |
MLYS | Rodman David Malcom | — | Feb 13, 2026 | Proposed Sale | $27.44 | 14,055 | $385.7K | — | |
MLYS | Rodman David Malcom | — | Feb 12, 2026 | Proposed Sale | $28.99 | 6,349 | $184.1K | — | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 9, 2026 | Sale | $30.21 | 2,171 | $65.6K | 50,437 | |
MLYS | David Malcom Rodman | Chief Medical Officer | Feb 9, 2026 | Option Exercise | $16.00 | 2,171 | $34.7K | 52,608 | |
MLYS | Rodman David Malcom | — | Feb 9, 2026 | Proposed Sale | $30.21 | 2,171 | $65.6K | — |